Cannabinoid Combination: Patent Filing Trends (Jan 2009- Jun 2019)

Currently, a combination of marijuana cannabinoids including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is used as a drug to treat muscle spasticity in patients with Multiple Sclerosis (MS).

Earlier there wasn’t any cure for multiple sclerosis but a combination therapy using THC and CBD results in amelioration of EAE and interestingly EAE mice showed an increase in the mucin degrading bacterial species.

Similarly, researchers are finding different possible combinations to use medical marijuana more effectively. There are 65 patent families filed in the cannabinoid combination.

Researchers are using cannabinoid combinations with non-synthetic compounds to increase the efficacy. For example, researchers are experimenting on a combination of one or multiple active pharmaceuticals ingredients with the cannabinoids to increase the therapeutic efficacy or to decrease the side effects associated with it. There are 83 patent families filed under this tech area.

Explore Other Patent Statistics on Cannabis Industry

Related Articles

Orbit Fab Patents – Insights & Stats (Updated 2023)

Orbit Fab has a total of 21 patents globally, out of which 8 have been granted. Of these 21 patents, more than 90% patents are active. The United States of America is where Orbit Fab has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, USA

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.